| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/17/2013 | US20130017995 Modified animal erythropoietin polypeptides and their uses |
| 01/17/2013 | US20130017994 Methods of Treating Glucose Metabolism Disorders |
| 01/17/2013 | US20130017993 Glycoside derivatives and uses thereof |
| 01/17/2013 | US20130017991 Hcv protease inhibitors and uses thereof |
| 01/17/2013 | US20130017260 Oral pharmaceutical formulations for the treatment of human canities |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017250 Methods For High Density Lipoprotein Cholesterol Regulation |
| 01/17/2013 | US20130017226 TNF-A and TWEAK Dual Antagonist for the Prophylaxis and Treatment of Autoimmune Diseases |
| 01/17/2013 | US20130017225 Natural plant products for control of cancer metastasis |
| 01/17/2013 | US20130017211 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 01/17/2013 | US20130017205 Inhibition of AXL Signaling in Anti-Metastatic Therapy |
| 01/17/2013 | US20130017204 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae |
| 01/17/2013 | US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
| 01/17/2013 | US20130017185 Thermostable Phytase Variants |
| 01/17/2013 | US20130017184 Stabilised solid compositions of factor VII polypeptides |
| 01/17/2013 | US20130017182 Multi-criteria optimized dietary supplement formulations |
| 01/17/2013 | US20130017177 Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof |
| 01/17/2013 | US20130017173 Novel compositions and methods for treating inflammatory bowel disease and airway inflammation |
| 01/17/2013 | US20130017172 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
| 01/17/2013 | US20130017171 Methods and compositions for treating hepatitis c virus |
| 01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/17/2013 | US20130017169 Multimeric forms of therapeutic proteins and uses thereof |
| 01/17/2013 | US20130017168 Methods for enhancing the efficacy of il-2 mediated immune responses |
| 01/17/2013 | US20130017150 Methods for prevention and treatment of acute renal injury |
| 01/17/2013 | CA2878701A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | CA2842105A1 Method of use of activated functional proteins to improve animal health |
| 01/17/2013 | CA2841917A1 Methods for treatment of incontinence associated with sexual activity |
| 01/17/2013 | CA2841890A1 Hbv polymerase mutants |
| 01/17/2013 | CA2841548A1 Sumoylation of serca2a and cardiovascular disease |
| 01/17/2013 | CA2841516A1 Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment |
| 01/17/2013 | CA2841445A1 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 01/17/2013 | CA2841139A1 Method for treatment of autonomic nervous system disorders |
| 01/17/2013 | CA2841135A1 Method for treatment of esophageal spasm |
| 01/17/2013 | CA2841066A1 Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
| 01/17/2013 | CA2840719A1 Antagonist peptide of the bond between cd47 and a protein belonging to the thrombospondin family |
| 01/17/2013 | CA2839747A1 Eosinophil peroxidase compositions and methods of their use |
| 01/16/2013 | EP2545935A1 HLS-5, a control sumoylation agent |
| 01/16/2013 | EP2545934A1 Aequorin-containing compositions and methods of using same |
| 01/16/2013 | EP2545933A2 Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| 01/16/2013 | EP2545171A1 Hjurp peptides and vaccines including the same |
| 01/16/2013 | EP2545070A1 Stat3 activation inhibitors |
| 01/16/2013 | EP2544721A1 Non-aqueous high concentration reduced viscosity suspension formulations |
| 01/16/2013 | EP2544706A1 Modulating aquaporins with relaxin |
| 01/16/2013 | EP2544705A2 Therapy for influenza like illness |
| 01/16/2013 | EP2544704A2 Sparc angiogenic domain and methods of use |
| 01/16/2013 | EP2544702A1 Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials |
| 01/16/2013 | EP2544701A2 Polymeric drug delivery conjugates and methods of making and using thereof |
| 01/16/2013 | EP2544697A2 Process,tube and device for the preparation of wound healant composition |
| 01/16/2013 | EP2544688A2 Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| 01/16/2013 | EP2544668A2 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 01/16/2013 | CN1954073B Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 01/16/2013 | CN1926242B Sialytated glycoproteins-process conditions and an efficient method for their production |
| 01/16/2013 | CN1925867B Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
| 01/16/2013 | CN1878541B Microparticles comprising somatostatin analogues |
| 01/16/2013 | CN1838954B Glycogen synthase kinase-3 inhibitors |
| 01/16/2013 | CN1495197B G-CSF analogs composition and its preparation method |
| 01/16/2013 | CN1454257B Production of recombinant blood clotting factors in human cell lines |
| 01/16/2013 | CN102884190A HJURP peptides and vaccines including the same |
| 01/16/2013 | CN102884181A Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 01/16/2013 | CN102884077A Conjugated FVIII variants |
| 01/16/2013 | CN102884076A Robo1-Fc fusion protein and use thereof for treating tumours |
| 01/16/2013 | CN102884075A Method for inhibiting HIV replication in mammal and human cells |
| 01/16/2013 | CN102884074A Peptidomimetic macrocycles |
| 01/16/2013 | CN102884073A Peptides for promoting angiogenesis and a use thereof |
| 01/16/2013 | CN102883743A Process for the preparation of insulin-zinc complexes |
| 01/16/2013 | CN102883742A Modulating aquaporins with relaxin |
| 01/16/2013 | CN102883741A Therapy for influenza like illness |
| 01/16/2013 | CN102883740A Bifunctional molecules for inactivating HIV and blocking HIV |
| 01/16/2013 | CN102883739A Analogs of pitutary adenylate cyclase-activating polypeptide (PACAP) and methods for their use |
| 01/16/2013 | CN102883738A Compositions and methods for the treatment of angiogenesis-related eye diseases |
| 01/16/2013 | CN102883737A Method of treatment of type 2 diabetes |
| 01/16/2013 | CN102883736A Peptides for promoting angiogenesis and a use thereof |
| 01/16/2013 | CN102883735A Transdermal administration of peptides |
| 01/16/2013 | CN102883734A Biosynthetic proline/alanine random coil polypeptides and their uses |
| 01/16/2013 | CN102883712A Gastro-resistant enzyme pharmaceutical compositions |
| 01/16/2013 | CN102876770A Tumor metastasis marker gene and application thereof |
| 01/16/2013 | CN102876683A Conotoxin and biological preparation method and application thereof |
| 01/16/2013 | CN102876682A Schistosoma Japonicum polymorphism antigen gene and application thereof as vaccine |
| 01/16/2013 | CN102875667A HIV-1 (human immunodeficiency virus-1) peptide Env120-128 specificity TCR (T cell receptor), recombinant retroviral vector thereof and application |
| 01/16/2013 | CN102875666A Tuberculosis antigen specificity TCR (T cell receptor), recombinant retroviral vector thereof and application |
| 01/16/2013 | CN102875660A Virus induced protein Mig1 and application thereof |
| 01/16/2013 | CN102875659A Antibacterial peptide secreted by skins of northeast forest frog, and coding sequence and application thereof |
| 01/16/2013 | CN102875656A Immunoglobuline E (IgE) specific binding polypeptide and medical application thereof |
| 01/16/2013 | CN102875653A Alpha-conotoxin peptide, and medical composition, preparation method and purpose thereof |
| 01/16/2013 | CN102875651A Anti-tumor target-activated polypeptide doxorubicin and preparation method and application thereof |
| 01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
| 01/16/2013 | CN102875645A Thymic humoral factor THF-gamma2, its derivative, their synthetic method, and their application in antitumor drugs |
| 01/16/2013 | CN102875644A GRPAK/tetrahydroglyoxaline/RGD ternary conjugate as well as preparation method and application thereof |
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/16/2013 | CN102872455A Medicament for preventing in-stent restenosis after coronary stent implantation and preparation method |
| 01/16/2013 | CN102872454A Preparation for relieving piglet stress through drinking water |
| 01/16/2013 | CN102872453A Vaginal rejuvenation gel and preparation method thereof |
| 01/16/2013 | CN102872452A Low sodium and low potassium enteral total nutrient |
| 01/16/2013 | CN102872451A Liquid composition of factor vii polypeptides |
| 01/16/2013 | CN102872450A Composition for composite drug administration |
| 01/16/2013 | CN102872449A Method for establishing hypothyroidism Wistar rat eye socket model |
| 01/16/2013 | CN102872448A Preparation of recombinant sophora lopecuraides agglutinin and application thereof |
| 01/16/2013 | CN102872447A Antimicrobial peptide, compositions, and methods of use |
| 01/16/2013 | CN102872446A Method for preparing anti-thrombosis and thrombolysis oral liquid |